Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
8,896,104
-
Total 13F shares
-
281,569
-
Share change
-
+11,753
-
Total reported value
-
$403,059
-
Price per share
-
$1.43
-
Number of holders
-
15
-
Value change
-
+$6,035
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) as of Q4 2024
As of 31 Dec 2024,
BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
281,569 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, StoneX Group Inc., Wealth Alliance, MORGAN STANLEY, CITADEL ADVISORS LLC, VANGUARD GROUP INC, STATE STREET CORP, US FINANCIAL ADVISORS, LLC, UBS Group AG, and Newman Dignan & Sheerar, Inc..
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.